PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
Federica Liotti(Institute for Experimental Endocrinology and Oncology), Rosa Marina Melillo(Institute for Experimental Endocrinology and Oncology)
Cited by 83
Related Papers
Molecular Mechanism of 17-Allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL Receptor Tyrosine Kinase Degradation
|Journal of Biological Chemistry|2013|54
A cell-autonomous PD-1/PD-L1 circuit promotes tumorigenicity of thyroid cancer cells by activating a SHP2/Ras/MAPK signalling cascade
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0
Faculty Opinions recommendation of Chemical genetic discovery of targets and anti-targets for cancer polypharmacology.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2012|0